Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1973 Aug;4(2):85–93. doi: 10.1128/aac.4.2.85

Antimicrobial Susceptibility of Nocardia Species

Phillip I Lerner a,1, Gerald L Baum a
PMCID: PMC444511  PMID: 4790942

Abstract

Variations of inoculum, pH, and composition of the agar assay media each influenced the in vitro susceptibility of Nocardia organisms (30 strains of N. asteroides and 6 strains of N. brasiliensis) to one or more antimicrobial agents incorporated in solid agar and incubated at 37 C for 48 h. Among newer antimicrobial agents, doxycycline, minocycline, and 7-halogenated lincomycin analogues exhibited the most consistent in vitro inhibitory activity; among older agents, viomycin, erythromycin, and streptomycin exhibited more selective in vitro inhibitory activity, but against a significant percentage of strains tested. N. brasiliensis was conspicuously more susceptible to erythromycin and gentamicin and more resistant to viomycin and capreomycin than was N. asteroides. Cycloserine demonstrated no significant in vitro inhibitory activity when assayed in appropriately augmented alanine-free medium. The outstanding feature of this in vitro survey was the marked variation in susceptibility among individual strains of N. asteroides, which variation deserves more careful consideration in future clinical or experimental therapeutic trials.

Full text

PDF
85

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAUER A. W., SHERRIS J. C. THE DETERMINATION OF SULFONAMIDE SUSCEPTIBILITY OF BACTERIA. Chemotherapy. 1964;9(1):1–19. doi: 10.1159/000220337. [DOI] [PubMed] [Google Scholar]
  2. Bach M. C., Sabath L. D., Finland M. Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother. 1973 Jan;3(1):1–8. doi: 10.1128/aac.3.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baikie A. G., Macdonald C. B., Mundy G. R. Systemic nocardiosis treated with trimethoprim and sulphamethoxazole. Lancet. 1970 Aug 1;2(7666):261–261. doi: 10.1016/s0140-6736(70)92606-1. [DOI] [PubMed] [Google Scholar]
  4. Black W. A., McNellis D. A. Sensitivity of Nocardia to trimethoprim and sulphonamides in vitro. J Clin Pathol. 1970 Jul;23(5):423–426. doi: 10.1136/jcp.23.5.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Black W. A., McNellis D. A. Susceptibility of Nocardia species to modern antimicrobial agents. Antimicrob Agents Chemother (Bethesda) 1970;10:346–349. [PubMed] [Google Scholar]
  6. Garrod L. P., Waterworth P. M. A study of antibiotic sensitivity testing with proposals for simple uniform methods. J Clin Pathol. 1971 Dec;24(9):779–789. doi: 10.1136/jcp.24.9.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HOEPRICH P. D. ALANINE--CYCLOSERINE ANTAGONISM. V. OCCURRENCE AMONG ACID-FAST BACILLI. Am Rev Respir Dis. 1964 Oct;90:646–648. doi: 10.1164/arrd.1964.90.4.646. [DOI] [PubMed] [Google Scholar]
  8. Mason K. N., Hathaway B. M. A study of Nocardia asteroides. White mice used as test animals. Arch Pathol. 1969 Apr;87(4):389–392. [PubMed] [Google Scholar]
  9. Matsen J. M. In vitro study of clindamycin and five other lincomycin analogs against strains of Haemophilus influenzae. J Lab Clin Med. 1971 Mar;77(3):378–383. [PubMed] [Google Scholar]
  10. Orfanakis M. G., Wilcox H. G., Smith C. B. In vitro studies of the combined effect of ampicillin and sulfonamides on Nocardia asteroides and results of therapy in four patients. Antimicrob Agents Chemother. 1972 Mar;1(3):215–220. doi: 10.1128/aac.1.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. PEABODY J. W., Jr, SEABURY J. H. Actinomycosis and nocardiosis. A review of basic differences in therapy. Am J Med. 1960 Jan;28:99–115. doi: 10.1016/0002-9343(60)90226-6. [DOI] [PubMed] [Google Scholar]
  12. PELLEGRINO E. D., HENDERSON R. R. Response of pulmonary nocardiosis to treatment with massive doses of penicillin intravenously. Report of a successfully treated case with four-year follow-up observation, together with review of the literature. Am Rev Respir Dis. 1961 Aug;84:242–255. doi: 10.1164/arrd.1961.84.2.242. [DOI] [PubMed] [Google Scholar]
  13. Powers K. G., Jacobs R. L. Activity of two chlorinated lincomycin analogues against chloroquine-resistant falciparum malaria in owl monkeys. Antimicrob Agents Chemother. 1972 Jan;1(1):49–53. doi: 10.1128/aac.1.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. RUNYON E. H. Nocardia asteroides; studies of its pathogenicity and drug sensitivities. J Lab Clin Med. 1951 May;37(5):713–720. [PubMed] [Google Scholar]
  15. SANFORD J. P., HATTEN B. E., FORDTRAN J. S. Effectiveness of novobiocin and cycloserine on Nocardia asteroides; preliminary evaluation in vitro and in vivo. Antibiot Annu. 1957;5:22–26. [PubMed] [Google Scholar]
  16. STRAUSS R. E., KLIGMAN A. M., PILLSBURY D. M. The chemotherapy of actinomycosis and nocardiosis. Am Rev Tuberc. 1951 Apr;63(4):441–448. doi: 10.1164/art.1951.63.4.441. [DOI] [PubMed] [Google Scholar]
  17. Sabath L. D., Gerstein D. A., Finland M. Enhanced activity of novobiocin against gram-negative bacilli in acid media. Antimicrob Agents Chemother (Bethesda) 1968;8:398–404. [PubMed] [Google Scholar]
  18. Sabath L. D., Lorian V., Gerstein D., Loder P. B., Finland M. Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria. Appl Microbiol. 1968 Sep;16(9):1288–1292. doi: 10.1128/am.16.9.1288-1292.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tanzil H. O., Widjaja C. The in vitro activity of framycetin against various species of Nocardia as an aid in the differentiation of nocardia. Am Rev Respir Dis. 1971 Feb;103(2):278–279. doi: 10.1164/arrd.1971.103.2.278. [DOI] [PubMed] [Google Scholar]
  20. Wilson D. E., Williams T. W., Jr In vitro susceptibility of Nocardia to antimicrobial agents. Antimicrob Agents Chemother (Bethesda) 1965;5:408–411. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES